LONDON--(BUSINESS WIRE)--Technavio has been monitoring the POC HbA1C testing market and it is poised to grow by USD 203.16 million during 2020-2024, progressing at a CAGR of almost 9% during the ...

Dublin, April 14, 2020 (GLOBE NEWSWIRE) -- The "POC HbA1C Testing Global Market Opportunities and Strategies to 2030" report has been added to ResearchAndMarkets.com's offering. This report from the ...

LONDON, March 31, 2020 /PRNewswire/ -- TheBusinessResearchCompany.com offers "POC HbA1C Testing Market By Product (Instruments, Consumables), By Technology (Ion-Exchange HPLC, Enzymatic Assay, ...

Dublin, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The "POC HbA1C Testing Market Opportunities and Strategies to 2033" report has been added to ResearchAndMarkets.com's offering. The Point-of-Care (POC) ...

Today, biosurfit SA (“biosurfit”), the in vitro point-of-care (PoC) diagnostics company, announces CE Marking (Conformité Européenne) for its HbA1c (Haemoglobin A1c) test, the third in a series of ...

EKF Diagnostics, the global in vitro diagnostics company, has announced the successful evaluation of its Quo-Lab® point-of-care HbA1c analyzer by the European Reference Laboratory for Glycohemoglobin.

EKF Diagnostics, the global in-vitro diagnostics company, announces that its Quo-Test ® HbA1c analyzer is successfully supporting improved medical management of patients with sight-threatening ...

LONDON--(BUSINESS WIRE)--Technavio has been monitoring the POC HbA1C testing market and it is poised to grow by USD 203.16 million during 2020-2024, progressing at a CAGR of almost 9% during the ...